Arvīds Irmejs

447 total citations
38 papers, 215 citations indexed

About

Arvīds Irmejs is a scholar working on Genetics, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Arvīds Irmejs has authored 38 papers receiving a total of 215 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Genetics, 14 papers in Pathology and Forensic Medicine and 14 papers in Cancer Research. Recurrent topics in Arvīds Irmejs's work include BRCA gene mutations in cancer (19 papers), Genetic factors in colorectal cancer (10 papers) and Breast Cancer Treatment Studies (8 papers). Arvīds Irmejs is often cited by papers focused on BRCA gene mutations in cancer (19 papers), Genetic factors in colorectal cancer (10 papers) and Breast Cancer Treatment Studies (8 papers). Arvīds Irmejs collaborates with scholars based in Latvia, Poland and United States. Arvīds Irmejs's co-authors include Jānis Gardovskis, Edvīns Miklaševičs, Miki Nakazawa, Gunta Purkalne, Ilze Štrumfa, Arnis Āboliņš, Marianna Bitiņa, Janina Suchy, Egils Vjaters and Yael Laitman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and European Journal of Cancer.

In The Last Decade

Arvīds Irmejs

35 papers receiving 209 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arvīds Irmejs Latvia 10 101 100 92 65 41 38 215
Ingrid Petroni Ewald Brazil 8 149 1.5× 164 1.6× 79 0.9× 109 1.7× 31 0.8× 12 288
Ewa A. Bergmann United States 3 98 1.0× 48 0.5× 77 0.8× 40 0.6× 36 0.9× 3 177
Alessia Fiorino Italy 9 130 1.3× 129 1.3× 76 0.8× 118 1.8× 72 1.8× 17 281
Eva Tornero Spain 8 142 1.4× 177 1.8× 93 1.0× 39 0.6× 56 1.4× 15 254
Mathilde Warcoin France 5 148 1.5× 95 0.9× 78 0.8× 103 1.6× 100 2.4× 7 270
Ester Castellsagué Spain 6 88 0.9× 90 0.9× 99 1.1× 73 1.1× 124 3.0× 7 220
Monica Marabelli Italy 7 87 0.9× 90 0.9× 65 0.7× 57 0.9× 81 2.0× 17 185
Małgorzata Czetwertyńska Poland 8 146 1.4× 111 1.1× 115 1.3× 43 0.7× 24 0.6× 10 317
Olga Campos Spain 9 138 1.4× 129 1.3× 96 1.0× 67 1.0× 100 2.4× 18 270
Tadeusz Dębniak Poland 9 111 1.1× 160 1.6× 69 0.8× 67 1.0× 80 2.0× 14 246

Countries citing papers authored by Arvīds Irmejs

Since Specialization
Citations

This map shows the geographic impact of Arvīds Irmejs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arvīds Irmejs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arvīds Irmejs more than expected).

Fields of papers citing papers by Arvīds Irmejs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arvīds Irmejs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arvīds Irmejs. The network helps show where Arvīds Irmejs may publish in the future.

Co-authorship network of co-authors of Arvīds Irmejs

This figure shows the co-authorship network connecting the top 25 collaborators of Arvīds Irmejs. A scholar is included among the top collaborators of Arvīds Irmejs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arvīds Irmejs. Arvīds Irmejs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Irmejs, Arvīds, et al.. (2024). Novel Nipple Reinnervation Technique Using N. Suralis Graft. Medicina. 60(9). 1533–1533. 1 indexed citations
2.
Purkalne, Gunta, et al.. (2023). Pathological complete response to neoadjuvant chemotherapy in triple negative breast cancer – single hospital experience. Hereditary Cancer in Clinical Practice. 21(1). 4–4. 9 indexed citations
3.
Irmejs, Arvīds, Margit Nõukas, Mart Kals, et al.. (2022). Spectrum and frequency of CHEK2 variants in breast cancer affected and general population in the Baltic states region, initial results and literature review. European Journal of Medical Genetics. 65(5). 104477–104477. 5 indexed citations
4.
Esgueva, Antonio, Iris Noordhoek, Elma Meershoek‐Klein Kranenbarg, et al.. (2021). Health-Related Quality of Life After Nipple-Sparing Mastectomy: Results From the INSPIRE Registry. Annals of Surgical Oncology. 29(3). 1722–1734. 5 indexed citations
8.
Irmejs, Arvīds, et al.. (2019). Role of Percutaneous Needle Biopsy of Axillary Lymph Nodes to Evaluate Node Positive Breast Cancer after Neoadjuvant Chemotherapy. Proceedings of the Latvian Academy of Sciences Section B Natural Exact and Applied Sciences. 73(4). 368–372. 1 indexed citations
9.
Irmejs, Arvīds, et al.. (2018). Platinum-based neoadjuvant chemotherapy in BRCA1-positive breast cancer: a retrospective cohort analysis and literature review. Hereditary Cancer in Clinical Practice. 16(1). 9–9. 12 indexed citations
10.
Nakazawa, Miki, Ilze Štrumfa, Arnis Āboliņš, et al.. (2015). High expression of miR-214 is associated with a worse disease-specific survival of the triple-negative breast cancer patients. Hereditary Cancer in Clinical Practice. 13(1). 7–7. 22 indexed citations
11.
Irmejs, Arvīds, et al.. (2013). Underestimated survival predictions of the prognostic tools Adjuvant! Online and PREDICT in BRCA1-associated breast cancer patients. Familial Cancer. 12(4). 683–689. 11 indexed citations
12.
13.
Irmejs, Arvīds, et al.. (2013). Prognostic role of BRCA1 mutation in patients with triple-negative breast cancer. Oncology Letters. 7(1). 278–284. 23 indexed citations
14.
Irmejs, Arvīds, et al.. (2012). Challenges in the management of a patient with Cowden syndrome: case report and literature review. Hereditary Cancer in Clinical Practice. 10(1). 5–5. 12 indexed citations
15.
Irmejs, Arvīds, et al.. (2011). Genotype-phenotype correlations among BRCA14153delA and 5382insC mutation carriers from Latvia. BMC Medical Genetics. 12(1). 147–147. 14 indexed citations
16.
Štrumfa, Ilze, et al.. (2009). Biliary Cystic Tumours with Mesenchymal Stroma. 9(1). 95–99. 1 indexed citations
17.
Kaufman, Bella, Yael Laitman, Jacek Gronwald, et al.. (2009). Haplotypes of the I157T CHEK2 germline mutation in ethnically diverse populations. Familial Cancer. 8(4). 473–478. 9 indexed citations
18.
Irmejs, Arvīds, Marianna Bitiņa, Grzegorz Kurzawski, et al.. (2007). Nationwide study of clinical and molecular features of hereditary non-polyposis colorectal cancer (HNPCC) in Latvia.. PubMed. 27(1B). 653–8. 3 indexed citations
19.
Irmejs, Arvīds, et al.. (2006). Pilot Study on Low Penetrance Breast and Colorectal Cancer Predisposition Markers in Latvia. Hereditary Cancer in Clinical Practice. 4(1). 48–51. 16 indexed citations
20.
Irmejs, Arvīds, et al.. (2003). Die Rolle der laparoskopischen Chirurgie bei schwerer akuter Pankreatitis. Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie. 128(10). 858–861. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026